Correlations between umbilical and maternal serum resistin levels and neonatal birth weight

References

• Abrams B, Pickett KE. Maternal nutrition. Maternal-fetal Medicinefourth edition, RK Creasy, R Resnik. W.B. Saunders Company, Philadelphia, PA 1999; 122–31
   Google Scholar
• Sivan E, Lin WM, Homko CJ, Reece EA, Boden G. Leptin is present in human cord blood. Diabetes 1997; 46: 917–9
   PubMed Web of Science ®Google Scholar
• Schubring C, Kiess W, Englaro P, Rascher W, Dotsch J, Hanitsch S, et al. Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab 1997; 82: 1480–3
   PubMed Web of Science ®Google Scholar
• Matsuda J, Yokota I, Iida M, Murakami T, Naito E, Ito M, et al. Serum leptin concentration in cord blood: relationship to birth weight and gender. J Clin Endocrinol Metab 1997; 82: 1642–4
   PubMed Web of Science ®Google Scholar
• Reitman ML, Bi S, Marcus-Samuels B, Gavrilova O. Leptin and its role in pregnancy and fetal development: an overview. Biochem Soc Trans 2001; 29: 68–72
   PubMed Web of Science ®Google Scholar
• Hoggard N, Haggarty P, Thomas L, Lea RG. Leptin expression in placental and fetal tissues: does leptin have a functional role?. Biochem Soc Trans 2001; 29: 57–63
   PubMed Web of Science ®Google Scholar
• Sagawa N, Yura S, Itoh H, Mise H, Kakui K, Korita D, et al. Role of leptin in pregnancy: a review. Placenta 2002; 23: 80–6
   PubMed Web of Science ®Google Scholar
• Yura S, Sagawa N, Itoh H, Kakui K, Nuamah MA, Korita D, et al. Resistin is expressed in the human placenta. J Clin Endocrinol Metab 2003; 88: 1394–7
   PubMed Web of Science ®Google Scholar
• Chen D, Dong M, Fang Q, He J, Wang Z, Yang X. Alterations of serum resistin in normal pregnancy and pre-eclampsia. Clin Sci 2005; 108: 81–4
   PubMed Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307–12
   PubMed Web of Science ®Google Scholar
• Juan CC, Au LC, Fang VS, Kang SF, Ko YH, Kuo SF, et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun 2001; 289: 1328–33
   PubMed Web of Science ®Google Scholar
• Le Lay S, Boucher J, Rey A, Castan-Laurell I, Krief S, Ferre P, et al. Decreased resistin expression in mice with different sensitivities to a high-fat diet. Biochem Biophys Res Commun 2001; 289: 564–7
   PubMed Web of Science ®Google Scholar
• Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 2001; 276: 25651–3
   PubMed Web of Science ®Google Scholar
• Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 2002; 10: 1–5
   PubMedGoogle Scholar
• Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 2001; 285: 561–4
   PubMed Web of Science ®Google Scholar
• Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001; 50: 2199–202
   PubMed Web of Science ®Google Scholar
• Engert JC, Vohl MC, Williams SM, Lepage P, Loredo-Osti JC, Faith J, et al. 5′ flanking variants of resistin are associated with obesity. Diabetes 2002; 51: 1629–34
   PubMed Web of Science ®Google Scholar
• Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, et al. Plasma resistin concentrations measured by ELISA using a newly-developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 150–6
   PubMed Web of Science ®Google Scholar
• Cho YM, Youn BS, Chung SS, Kim KW, Lee HK, Yu KY, et al. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 2004; 47: 1337–8
   Web of Science ®Google Scholar
• Wang H, Chu WS, Hemphill C, Elbein SC. Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002; 87: 2520–4
   PubMed Web of Science ®Google Scholar
• Ng PC, Lee CH, Lam CW, Chan IH, Wong E, Fok TF. Resistin in preterm and term newborns: relation to anthropometry, leptin, and insulin. Pediatr Res 2005; 58: 725–30
   PubMed Web of Science ®Google Scholar
• Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC, et al. Williams's obstetricstwentieth edition. Appleton & Lange, Norwalk, CT 1997; 151–90
   Google Scholar
• McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002; 87: 2407
   PubMed Web of Science ®Google Scholar
• Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276: 11252–6
   PubMed Web of Science ®Google Scholar
• Ng PC, Lee CH, Lam CW, Wong E, Chan IH, Fok TF. Plasma ghrelin and resistin concentrations are suppressed in infants of insulin-dependent diabetic mothers. J Clin Endocrinol Metab 2004; 89: 5563–8
   PubMed Web of Science ®Google Scholar
• Rajala MW, Lin Y, Ranalletta M, Yang XM, Qian H, Gingerich R, et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol 2002; 16: 1920–30
   PubMedGoogle Scholar